MED.DE XETRA
Mediclin AG
1W: -4.7%
1M: -7.3%
3M: +26.9%
YTD: +32.1%
1Y: +70.0%
3Y: +77.1%
5Y: +33.9%
€5.10 ($5.72)
-0.00 (-0.00%)
Weekly Expected Move ±3.9%
€5
€5
€5
€5
€5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$100M
+24.0% ▲
5Y CAGR: -3.4%
Capital Expenditures
$48M
-8.4% ▼
5Y CAGR: +13.4%
Free Cash Flow
$51M
+43.4% ▲
5Y CAGR: -11.2%
Dividends Paid
$2M
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$35M
-358.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1M | $10M | -$11M | $25M | $25M |
| Depreciation & Amort. | $74M | $71M | $86M | $50M | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $2M | -$49M | -$25M | -$21M | -$4M |
| Other Non-Cash Items | $5M | $3M | $28M | $26M | $79M |
| Operating Cash Flow | $82M | $35M | $78M | $81M | $100M |
| — Investing Activities — | |||||
| Capital Expenditures | -$17M | -$26M | -$38M | -$38M | -$51M |
| Acquisitions (Net) | $10M | $19M | $470K | $10M | $309K |
| Investment Purchases | -$38K | -$42K | -$42K | -$10K | $0 |
| Investment Sales | -$1M | $2M | $19M | $0 | $0 |
| Other Investing | $2M | -$974K | $9M | $13M | $14M |
| Investing Cash Flow | -$7M | -$6M | -$10M | -$15M | -$37M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$2M | -$2M | -$2M | -$50M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | -$2M |
| Other Financing | -$53M | -$54M | -$44M | -$23M | -$96M |
| Financing Cash Flow | -$55M | -$56M | -$45M | -$73M | -$97M |
| Net Change in Cash | $20M | -$28M | $23M | -$8M | -$35M |
| Cash End of Period | $120M | $92M | $115M | $108M | $72M |
| Free Cash Flow | $65M | $9M | $40M | $36M | $51M |